Prevalence of a Localized or Diffuse Pruritus in a Population With One or Several, Primitive or Secondary, Brain Tumor(s)

NCT03673878 | Completed

• 1 other identifier: 29BRC18.0155
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

The association between the presence of pruritus, especially centrofacial, and the presence of a brain tumor is a widespread notion in the medical community but based on a single publication by Andreev et al. in the British Journal of Dermatology published in 1975. No other study has studied this association with a rigorous methodology. The aim of this study is to evaluate the prevalence of pruritus in patients with one or more primary or secondary brain tumor(s), benign(s) or malignant(s).

Conditions

Pruritus; Brain Tumor

Outcome Measures

Primary Outcomes (1)

• Presence of itching for more than 1 week in a patient with one or more brain tumor(s), primary or secondary, benign(s) or malignant(s).

  Presence of itching for more than 1 week in a patient with one or more brain tumor(s), primary or secondary, benign(s) or malignant(s).

  1 year

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patient who are seen in radiotherapy consultation and / or hospitalization of neurosurgery Fulfilling the inclusion criteria, not falling within the exclusion criteria Presence of itching for more than 1 week in a patient with one or more brain tumor(s), primary or secondary, benign(s) or malignant(s).

You may qualify if:

• Age \> 18 years
• Diagnosis of benign or malignant brain tumor, primary or secondary.
• Accepted non-opposition
• Realization of a cerebral MRI (cMRI)

You may not qualify if:

• Age \< 18 years
• Absence of cerebral imaging of the cMRI type
• Absence of non opposition
• Realization of a treatment modifying the brain structure (radiotherapy / surgery)

Sponsors & Collaborators

• University Hospital, Brest: lead

Study Sites (1)

Service de dermatologie, CHRU BREST

Brest, 29200, France

Location

MeSH Terms

Conditions

Pruritus; Brain Neoplasms

Condition Hierarchy (Ancestors)

Skin Diseases; Skin and Connective Tissue Diseases; Skin Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Central Nervous System Neoplasms; Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 14, 2018
• First Posted: September 17, 2018
• Study Start: June 29, 2020
• Primary Completion: September 5, 2021
• Study Completion: September 5, 2021
• Last Updated: January 27, 2022

Record last verified: 2022-01

Locations

FR (1)